Original language | English |
---|---|
Pages (from-to) | P26 |
Journal | Diabetic Medicine |
Volume | 21 |
Issue number | S2 |
Publication status | Published - 2004 |
(Lys9)GLP-1 lacks insulinotropic activity but acts as a potent novel GLP-1 receptor antagonist in vivo.
F.P.M. O'Harte, Brian Green, V.A. Gault, N. Irwin, Mark Mooney, Patrick Harriott, B. Greer, P.R. Flatt
Research output: Contribution to journal › Meeting abstract › peer-review
23
Citations
(Scopus)